Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation Therapy.
Yen-Chi LinPo-Hung LinI-Hung ShaoYuan-Cheng ChuHung-Cheng KanChung-Yi LiuKai-Jie YuYing-Hsu ChangSee-Tong PangJhen-Ling HuangCheng-Keng ChuangPublished in: Journal of oncology (2021)
PSADT is an effective clinical predictor for disease progression and survival in LVD. Other PSA kinetics including TTN and TFNTC, though not the major predictors for disease progression or OS in LVD, might be the predictors for disease control status.